Icosavax Inc ICVX
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover ICVX, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.
News
-
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ICVX, PGTI, IONM
-
INVESTIGATION ALERT: Halper Sadeh LLC Investigates CSTR, ICVX, BATL
-
Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law Firm
-
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CSTR, EGLE, ICVX
-
Icosavax Shares Take Flight on Takeover by AstraZeneca
-
AstraZeneca to Buy Icosavax for Up to $1.1 Billion — Update
-
AstraZeneca to Buy Icosavax for Up to $1.1 Billion
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Icosavax Inc is a biopharmaceutical company. It is committed towards developing safe and effective vaccines against infectious diseases against infectious diseases, with an initial focus on life-threatening respiratory diseases.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 60
- Website
- https://www.icosavax.com
Comparables
Valuation
|
Metric
|
ICVX
|
HLVX
|
SMMT
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 3.30 | 2.26 | 32.42 |
Price/Sales | — | — | — |
Price/Cash Flow | — | — | — |
Price/Earnings
ICVX
HLVX
SMMT
Financial Strength
|
Metric
|
ICVX
|
HLVX
|
SMMT
|
|---|---|---|---|
Quick Ratio | 17.59 | 10.37 | 9.17 |
Current Ratio | 18.06 | 10.62 | 9.30 |
Interest Coverage | — | −54.72 | −36.99 |
Quick Ratio
ICVX
HLVX
SMMT
Profitability
|
Metric
|
ICVX
|
HLVX
|
SMMT
|
|---|---|---|---|
Return on Assets (Normalized) | −29.30% | −34.03% | −25.32% |
Return on Equity (Normalized) | −31.87% | −42.52% | −71.75% |
Return on Invested Capital (Normalized) | −34.69% | −38.62% | −24.62% |
Return on Assets
ICVX
HLVX
SMMT
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Mzmrdhzdz | Ccxf | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Dwdxltc | Dnndyh | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Hqlvxrds | Rrfwqyv | $97.8 Bil | |
MRNA
| Moderna Inc | Qyzvrxg | Hbvy | $41.3 Bil | |
ARGX
| argenx SE ADR | Hflrpyxpl | Sqmqh | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Fjtdtgkjd | Jlzvq | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Rkyctszk | Dsrxwk | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Lnfqljgm | Gjrkjf | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Jmkwklhlmg | Slhjnx | $12.5 Bil | |
INCY
| Incyte Corp | Tpykpmrnk | Fmhmvqy | $11.6 Bil |